Preimplantation Genetic Diagnosis Market, By Type (Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single gene disorders, HLA Typing, Gender Selection, Others), By End User (Diagnostic Laboratories, Hospitals, Clinics, Others), By Geography (Nor

Preimplantation Genetic Diagnosis Market, By Type (Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single gene disorders, HLA Typing, Gender Selection, Others), By End User (Diagnostic Laboratories, Hospitals, Clinics, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)


Preimplantation genetic diagnosis (PGD) is an in-vitro fertilization procedure in which one or few cells are biopsied from an embryo before implantation and tested for genetic defects. PGD helps to identify genetic defects in embryos developed through IVF and assists in selective implantation of healthy embryos. It aids in preventing the transmission of hereditary disorders to offspring and allows couples to choose only embryos without genetic conditions. Factors such as rising infertility rates, increasing risk of chromosomal abnormalities with advancing maternal age, growing focus on prevention of genetic disorders, and technological advancements in PGD techniques can drive the global preimplantation genetic diagnosis market growth during the forecast period.

Market Dynamics:

Global preimplantation genetic diagnosis market growth is driven by rising infertility rates, growing focus on prevention of genetic disorders, increasing maternal age globally that leads to higher chances of chromosomal abnormalities. However, limitations of PGD, social and ethical concerns regarding PGD, and stringent regulations can hamper the market growth. Various initiatives by government and private organizations to spread awareness about PGD can offer lucrative market growth opportunities. Market players are focusing on new techniques such as next-generation sequencing to provide comprehensive chromosome screening with improved outcomes.

Key Features of the Study:
  • This report provides in-depth analysis of the global preimplantation genetic diagnosis market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global preimplantation genetic diagnosis market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include CooperSurgical, Illumina, Thermo Fisher, Agilent Technologies, PerkinElmer, Abbott Laboratories, Natera, Rubicon Genomics, Oxford Gene Technology, Yikon Genomics
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global preimplantation genetic diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preimplantation genetic diagnosis market
Detailed Segmentation-
  • By Type:
  • Chromosomal Abnormalities
  • Aneuploidy
  • X-linked diseases
  • Single gene disorders
  • HLA Typing
  • Gender Selection
  • Others
  • By End User
  • Diagnostic Laboratories
  • Hospitals
  • Clinics
  • Others
  • By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
  • Company Profiles:
  • PerkinElmer, Inc.
  • Genea Limited
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Quest Diagnostics Incorporated
  • Illumina, Inc.
  • CooperSurgical, Inc.
  • Beijing Genomics Institute (BGI)
  • LabCorp of America Holdings (Laboratory Corporation of America)
  • Natera, Inc.
  • Oxford Gene Technology
  • California Pacific Medical Center
  • Good Start Genetics, Inc.
  • Invitae Corporation
  • F. Hoffmann-La Roche AG
  • Progenesis


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Type
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter’s Analysis
4. Global Preimplantation Genetic Diagnosis Market - Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the Market
5. Global Preimplantation Genetic Diagnosis Market, By Type, 2019 – 2031, (USD Mn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Chromosomal Abnormalities
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Aneuploidy
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
X-linked diseases
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Single gene disorders
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
HLA Typing
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Gender Selection
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
6. Global Preimplantation Genetic Diagnosis Market, By End User, 2019 – 2031, (USD Mn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Diagnostic Laboratories
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Hospitals
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Clinics
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
7. Global Preimplantation Genetic Diagnosis Market, By Region, 2019 – 2031, (USD Mn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Region, 2020–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Mn)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Company Profiles
PerkinElmer, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Genea Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Thermo Fisher Scientific Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Agilent Technologies, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Quest Diagnostics Incorporated
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Illumina, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
CooperSurgical, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Beijing Genomics Institute (BGI)
LabCorp of America Holdings (Laboratory Corporation of America)
Natera, Inc.
Oxford Gene Technology
California Pacific Medical Center
Good Start Genetics, Inc.
Invitae Corporation
F. Hoffmann-La Roche AG
Progenesis
9. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
10. References and Research Methodology
References
Research Methodology
About Us and Sales Contact
*Browse 32 market data tables and 28 figures on Preimplantation Genetic Diagnosis Market” - Global forecast to 2031

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings